Skip to main content

United States Biosimilar Market 2017 (Antibody, Hormone, Growth Factors and Other) Research Report Analysis, Size, Share, Growth, Trends and Forecast Opportunities to 2022

Press Release   •   Aug 10, 2017 03:26 EDT

In this report, the United States Biosimilar Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Click Here To Get Request Sample: http://globalqyresearch.com/download-sample/253656 

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Biosimilar in these regions, from 2012 to 2022 (forecast).

United States Biosimilar market competition by top manufacturers/players, with Biosimilar sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Roche
Eli Lilly
Bayer
Amgen
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Merck

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Antibody
Hormone
Growth Factors
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biosimilar for each application, including
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Ask Query Here:Jay@globalqyresearch.com or Sales@globalqyresearch.com

Table of Contents

United States Biosimilar Market Report 2017
1 Biosimilar Overview
1.1 Product Overview and Scope of Biosimilar
1.2 Classification of Biosimilar by Product Category
1.2.1 United States Biosimilar Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Biosimilar Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Antibody
1.2.4 Hormone
1.2.5 Growth Factors
1.2.6 Other
1.3 United States Biosimilar Market by Application/End Users
1.3.1 United States Biosimilar Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 United States Biosimilar Market by Region
1.4.1 United States Biosimilar Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Biosimilar Status and Prospect (2012-2022)
1.4.3 Southwest Biosimilar Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Biosimilar Status and Prospect (2012-2022)
1.4.5 New England Biosimilar Status and Prospect (2012-2022)
1.4.6 The South Biosimilar Status and Prospect (2012-2022)
1.4.7 The Midwest Biosimilar Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Biosimilar (2012-2022)
1.5.1 United States Biosimilar Sales and Growth Rate (2012-2022)
1.5.2 United States Biosimilar Revenue and Growth Rate (2012-2022)

2 United States Biosimilar Market Competition by Players/Suppliers
2.1 United States Biosimilar Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Biosimilar Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Biosimilar Average Price by Players/Suppliers (2012-2017)
2.4 United States Biosimilar Market Competitive Situation and Trends
2.4.1 United States Biosimilar Market Concentration Rate
2.4.2 United States Biosimilar Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Biosimilar Manufacturing Base Distribution, Sales Area, Product Type

3 United States Biosimilar Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Biosimilar Sales and Market Share by Region (2012-2017)
3.2 United States Biosimilar Revenue and Market Share by Region (2012-2017)
3.3 United States Biosimilar Price by Region (2012-2017)

4 United States Biosimilar Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Biosimilar Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Biosimilar Revenue and Market Share by Type (2012-2017)
4.3 United States Biosimilar Price by Type (2012-2017)
4.4 United States Biosimilar Sales Growth Rate by Type (2012-2017)

5 United States Biosimilar Sales (Volume) by Application (2012-2017)
5.1 United States Biosimilar Sales and Market Share by Application (2012-2017)
5.2 United States Biosimilar Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Biosimilar Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Biosimilar Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Roche
6.2.2 Biosimilar Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Roche Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly
6.3.2 Biosimilar Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Bayer
6.4.2 Biosimilar Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bayer Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Amgen
6.5.2 Biosimilar Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Amgen Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Sanofi-Aventis
6.6.2 Biosimilar Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi-Aventis Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
6.7.2 Biosimilar Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Johnson & Johnson Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Novo Nordisk
6.8.2 Biosimilar Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Novo Nordisk Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck
6.9.2 Biosimilar Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview

7 Biosimilar Manufacturing Cost Analysis
7.1 Biosimilar Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilar

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Biosimilar Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilar Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Biosimilar Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Biosimilar Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Biosimilar Sales Volume Forecast by Type (2017-2022)
11.3 United States Biosimilar Sales Volume Forecast by Application (2017-2022)
11.4 United States Biosimilar Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/253656

About Us:

Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 3239 2407

Comments (0)

Add comment

Comment